Valuation: genOway

Market Cap 22.13M 25.3M 20.41M 18.85M 35.77M 2.41B 36.37M 244M 95.77M 1.19B 94.99M 92.92M 4.09B P/E 2024 *
-
P/E 2025 -
Enterprise Value 28.85M 32.98M 26.61M 24.57M 46.63M 3.15B 47.41M 318M 125M 1.55B 124M 121M 5.33B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day+5.26%
1 week-0.41%
Current month+1.27%
1 month-0.83%
3 months-1.64%
6 months-4.00%
Current year-11.44%
1 week 2.21
Extreme 2.21
2.45
1 month 2.21
Extreme 2.21
2.46
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.28
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
22-01-19Buy

Chief Executive Officer

12,500 0.1376%
21-11-16Sell

Chief Executive Officer

5,000 0.0553%
21-11-12Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
+5.26%-0.41%-26.38%-37.66% 25.3M
+0.58%+2.06%+2.92%+10.86% 50.73B
-2.22%-1.25%+385.40%+586.81% 39.73B
-0.54%+0.39%+25.57%-5.28% 34.69B
-1.36%+0.35%+17.88%+55.14% 33.21B
+1.21%-4.58%+3.00%+35.46% 26.76B
-1.81%-1.48% - - 16.8B
+0.51%-3.47%+63.97%+122.60% 15.37B
+0.23%-0.58%+13.76%+21.11% 13.78B
-0.62%-3.09%+10.29%-31.35% 12.85B
Average +0.12%-0.79%+55.16%+84.19% 24.39B
Weighted average by Cap. -0.48%-0.23%+80.68%+124.30%

Financials

2024 2025
Net sales 27.53M 31.48M 25.39M 23.45M 44.5M 3B 45.25M 303M 119M 1.48B 118M 116M 5.08B 28.6M 32.7M 26.38M 24.37M 46.23M 3.12B 47.01M 315M 124M 1.54B 123M 120M 5.28B
Net income 1.83M 2.09M 1.69M 1.56M 2.96M 200M 3.01M 20.18M 7.92M 98.34M 7.86M 7.69M 338M 928K 1.06M 856K 790K 1.5M 101M 1.52M 10.22M 4.02M 49.83M 3.98M 3.9M 171M
Net Debt 623K 712K 575K 531K 1.01M 67.93M 1.02M 6.87M 2.7M 33.46M 2.67M 2.62M 115M 6.72M 7.68M 6.2M 5.72M 10.86M 733M 11.04M 74.04M 29.08M 361M 28.84M 28.21M 1.24B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-07-10 €2.400 +5.26% 13,168
26-07-09 €2.280 -2.98% 14,012
26-07-08 €2.350 -3.29% 4,244
26-07-07 €2.430 +0.41% 3,965
26-07-06 €2.420 +0.41% 3,607
  1. Stock Market
  2. Stocks
  3. ALGEN Stock